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A B S T R A C T
Background
Concerns exist regarding antibiotic prescribing for acute respiratory tract infections (ARTIs) owing to adverse reactions, cost and
antibacterial resistance. One strategy to reduce antibiotic prescribing is to provide prescriptions but to advise delay in the hope symptoms
will resolve first. This is an update of a Cochrane Review originally published in 2007 and updated in 2010.
Objectives
To evaluate the use of delayed antibiotics compared to immediate or no antibiotics as a prescribing strategy for ARTIs. We evaluated
clinical outcomes including duration and severity measures for pain, malaise, fever, cough and rhinorrhoea in sore throat, acute otitis
media, bronchitis (cough) and the common cold. We also evaluated the outcomes of antibiotic use, patient satisfaction, antibiotic
resistance and re-consultation rates and use of alternative therapies.
Search methods
We searched CENTRAL (The Cochrane Library 2013, Issue 2), which includes the Acute Respiratory Infection Group’s Specialised
Register; Ovid MEDLINE (January 1966 to February Week 3 2013); Ovid MEDLINE In-Process & Other Non-Indexed Citations
(28 February 2013); EMBASE (1990 to 2013 Week 08); Science Citation Index - Web of Science (2007 to May 2012) and EBSCO
CINAHL (1982 to 28 February 2013).
Selection criteria
Randomised controlled trials (RCTs) involving participants of all ages defined as having an ARTI, where delayed antibiotics were
compared to antibiotics used immediately or no antibiotics.
Data collection and analysis
Three review authors independently extracted and collected data. Important adverse effects, including adverse effects of antibiotics and
complications of disease, were included as secondary outcomes. We assessed the risk of bias of all included trials. We contacted trial
authors to obtain missing information where available.
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Main results
Ten studies, with a total of 3157 participants, were included in this review. Heterogeneity of the 10 included studies and their results
generally precluded meta-analysis with patient satisfaction being an exception.
There was no difference between delayed, immediate and no prescribed antibiotics for the clinical outcomes evaluated in cough and
common cold. In patients with acute otitis media (AOM) and sore throat immediate antibiotics were more effective than delayed for fever,
pain and malaise in some studies. There were only minor differences in adverse effects with no significant difference in complication
rates.
Delayed antibiotics resulted in a significant reduction in antibiotic use compared to immediate antibiotics. A strategy of no antibiotics
resulted in least antibiotic use.
Patient satisfaction favoured immediate antibiotics over delayed (odds ratio (OR) 0.52; 95% confidence interval (CI) 0.35 to 0.76).
Delayed and no antibiotics had similar satisfaction rates with both strategies achieving over 80% satisfaction (OR 1.44; 95% CI 0.99
to 2.10).
There was no difference in re-consultation rates for immediate and delayed groups.
None of the included studies evaluated antibiotic resistance.
Authors’ conclusions
Most clinical outcomes show no difference between strategies. Delay slightly reduces patient satisfaction compared to immediate
antibiotics (87% versus 92%) but not compared to none (87% versus 83%). In patients with respiratory infections where clinicians
feel it is safe not to prescribe antibiotics immediately, no antibiotics with advice to return if symptoms do not resolve is likely to result
in the least antibiotic use, while maintaining similar patient satisfaction and clinical outcomes to delayed antibiotics.
P L A I N L A N G U A G E S U M M A R Y
Delayed antibiotics for symptoms and complications of acute respiratory tract infections
Previous reviews indicate that antibiotics have, at best, only modest benefit for acute respiratory tract infections (ARTIs). These benefits
need to be balanced against adverse effects, costs and the risk of bacteria becoming resistant to antibiotics. One way for doctors to
reduce their use is to prescribe delayed antibiotics (meaning providing the prescription but advising the patient/carer to delay their
use in the hope that symptoms resolve first). Delayed prescribing resulted in 32% of patients using antibiotics compared to 93% of
patients in the immediate prescription group. However, not prescribing antibiotics at all results in the least antibiotic prescribing (14%
of patients used antibiotics).
This review found 10 studies, involving 3157 participants, looking at prescribing strategies for respiratory infections. It was generally
not possible to combine results from different studies because of incomplete information from some studies and the different types of
patients in each study. There were only three trials comparing the strategies of delayed and no antibiotics.
For most symptoms like fever, pain and malaise, there was no difference between immediate, delayed and no antibiotics. The only
differences were small and favoured immediate antibiotics for relieving pain and fever for sore throat and pain and malaise for middle
ear infections. There was little difference in adverse effects of antibiotics for the three prescribing strategies and no significant difference
in complication rates.
Patient satisfaction was slightly reduced in the delayed antibiotic group (87% satisfied) compared to the immediate antibiotic group
(92% satisfied). Satisfaction rates were similar between delayed and no antibiotic groups (83% satisfied).
No included studies evaluated antibiotic resistance.
When doctors feel it is safe not to prescribe antibiotics immediately, prescribing none with advice to return if symptoms do not resolve
rather than delaying them will result in lower subsequent antibiotic use, while maintaining similar patient satisfaction and symptom
outcomes.
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B A C K G R O U N D
Description of the condition
The use of antibiotics for acute respiratory tract infections (ARTIs)
is controversial. Empirical evidence suggests that antibiotics have
only a modest benefit in acute otitis media (AOM) (Venekamp
2013), pharyngitis (Spinks 2011) and acute bronchitis (Smith
2011) and no effect in the common cold (Arroll 2010). Any ben-
efits have to be weighed up against common adverse reactions (in-
cluding rash, abdominal pain, diarrhoea and vomiting) and cost
(Berman 1997; Niemela 1999). Over-prescribing may also con-
tribute to community bacterial resistance to antibiotics (Arason
1996; Brook 1998; Verkatesum 1995).
Description of the intervention
There has been interest in strategies to reduce antibiotic prescrib-
ing for ARTIs. One of these strategies is to advise patients to ’de-
lay’ filling their script and only to fill it if their symptoms per-
sist or deteriorate. Delayed antibiotics are advocated as a means
of demonstrating to patients that antibiotics are not always nec-
essary, without making them feel under-serviced (Arroll 2002b).
Two ways of using this strategy have been deployed: giving the
patient the antibiotic (with instructions not to use unless there is
deterioration); and making the prescription available at the clinic
reception (to be picked up in the event of deterioration).
How the intervention might work
Delaying antibioticsmay provide a feeling of safety for both patient
and clinician should an illness deteriorate. This intervention then
provides the safety of having a prescription of antibiotics available,
yet an educational way of experiencing whether the illness resolves
spontaneously without their use.
A systematic review showed that using delayed antibiotics in ARTIs
significantly reduces antibiotic prescribing (Arroll 2003a). The
reduction ranges from a risk ratio (RR) of 0.77 (95% confidence
interval (CI) 0.73 to 0.81) (Dowell 2001) to RR 0.25 (95% CI
0.19 to 0.34) (Little 1997).
Why it is important to do this review
The delayed antibiotic strategy has also been advocated more re-
cently as a safety net for avoiding rare but important complica-
tions of initially uncomplicated ARTIs (Little 2005b). The same
authors also advocated delayed antibiotics for reducing antibiotic
use, allowing adequate control of symptoms, while providing high
levels of patient satisfaction (Little 2005b).
This review asks specifically what effect delayed antibiotics have
on clinical outcomes of ARTIs compared to immediate antibiotics
and no antibiotics. This review also evaluates the available data
on antibiotic use, patient satisfaction and antibiotic resistance for
the three prescribing strategies of delayed antibiotics, immediate
antibiotics and no antibiotics. This is an update of a Cochrane
Review originally published in 2007 (Spurling 2007), with an
updated version published in 2010 (Spurling 2010).
O B J E C T I V E S
To evaluate the use of delayed antibiotics compared to immediate
or no antibiotics as a prescribing strategy for ARTIs. We aimed to
evaluate clinical outcomes including duration and severity mea-
sures for pain, malaise, fever, cough and rhinorrhoea in sore throat,
AOM, bronchitis (cough) and the common cold. We also aimed
to evaluate the outcomes of antibiotic use, patient satisfaction, an-
tibiotic resistance and re-consultation rates and use of alternative
therapies.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) studying the treatment of
ARTIs with delayed antibiotics versus immediate or no antibiotics.
Open randomised trials were accepted.
Types of participants
Patients of all ages defined as having ARTIs.
Types of interventions
1. ’Delayed antibiotic use’ was defined as a strategy involving
the use of or advice to use antibiotics more than 48 hours after
the initial consultation.
2. ’Immediate antibiotic use’ was defined as the immediate use
of a prescription of oral antibiotics given at the initial
consultation.
3. ’No antibiotic use’ was defined as no prescription of
antibiotics at the initial consultation.
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Types of outcome measures
Primary outcomes
We compared delayed antibiotics with immediate antibiotics and
delayed antibiotics with no antibiotics where data were available.
1. Clinical outcomes for sore throat, AOM, bronchitis
(cough) and common cold (we included duration and severity
measures for the following symptoms: pain, malaise, fever, cough
and rhinorrhoea)
2. Antibiotic use
3. Patient satisfaction (where patient satisfaction is measured
on a four to six-point Likert scale; we defined satisfaction as
including both satisfied and very satisfied)
4. Antibiotic resistance
Secondary outcomes
1. Adverse effects of antibiotics
2. Complications of disease
3. Re-consultation
4. Use of alternative therapies
Search methods for identification of studies
Electronic searches
For this updated review we searched the Cochrane Central Regis-
ter of Controlled Trials (CENTRAL) (The Cochrane Library 2013,
Issue 2), which includes the Acute Respiratory Infection Group’s
Specialised Register; Ovid MEDLINE (January 1966 to Febru-
ary Week 3 2013); Ovid MEDLINE In-Process & Other Non-
Indexed Citations (28 February 2013); EMBASE (1990 to 2013
Week 08); Science Citation Index - Web of Science (2007 to May
2012) and EBSCO CINAHL (1982 to 28 February 2013).
In the original version of this review MEDLINE was searched us-
ing the following keywords and MeSH terms in conjunction with
the highly sensitive search strategy designed byTheCochraneCol-
laboration for identifying randomised controlled trials (Dickersin
1994). For this update we applied no trial filters. We used the
MEDLINE search strategy to search CENTRAL (Appendix 1)
and adapted this to search EMBASE (Appendix 2) and CINAHL
(Appendix 3).
Ovid MEDLINE
1 exp Respiratory Tract Infections/ (114895)
2 (upper respiratory tract infection$ or urti).mp. (2482)
3 exp Otitis Media/ (8289)
4 otitis media.mp. (10100)
5 exp Pharyngitis/ (4870)
6 pharyngitis.mp. (3733)
7 exp Tonsillitis/ (2065)
8 tonsillitis.mp. (2423)
9 exp Common Cold/ (1492)
10 common cold.mp. (2207)
11 exp Bronchitis/ (8275)
12 bronchitis.mp. (8027)
13 exp Sinusitis/ (8071)
14 sinusitis.mp. (10465)
15 sore throat$.mp. (2080)
16 or/1-15 (133707)
17 exp Anti-Bacterial Agents/ (215537)
18 antibiotic$.mp. (127408)
19 or/17-18 (278179)
20 (delay$ adj15 prescri$).mp. (474)
21 and/16,19-20 (55)
There were no language or date of publication restrictions in any
of the electronic database searches.
Searching other resources
We scanned abstracts from the search results to identify trials that
loosely met the inclusion criteria. We checked references of all
relevant retrieved trials to identify any other articles.
Data collection and analysis
Selection of studies
In the original publication of this review, we scanned abstracts
from the initial search results to identify trials that loosely met the
inclusion criteria. We checked references of all relevant retrieved
trials to identify any other articles. Three review authors (RFo,
LD, CDM) independently reviewed the full-text articles of the
retrieved trials.
In the 2010 update, one further study was found to meet the in-
clusion criteria (Chao 2008) and two review authors (LD, CDM)
independently assessed the methodological quality of the new in-
cluded study that met the inclusion criteria at that time (Chao
2008).
Similarly, in this updated review (2013), three authors (RFo, GS,
RFa) scanned abstracts from the updated searches to identify trials
that met the inclusion criteria, checking the references of all re-
trieved trials to identify other articles. Three review authors (LD,
CDM, RFa) independently reviewed the full-text articles of the
retrieved trials and applied the inclusion criteria.
We identified two papers, Little 2006 andMoore 2009, as report-
ing longer-term outcomes from previously included studies (Little
2001; Little 2005a).
Data extraction and management
In the initial publication of this review, three review authors (RFo,
LD and CDM) independently extracted data for each study trial
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to be included. We extracted data in a blinded manner (that is,
without the knowledge of the study results, the names of the au-
thors, institutions or journal of publication). We extracted addi-
tional data from graphs of the published articles of El-Daher 1991
and Pichichero 1987 on fever severity and symptom scores.
In thismost recent update (2013), two review authors (LD,CDM)
independently extracted data from the two new included papers.
We contacted the authors of Little 2006 to obtain original data
for the outcomes of earache at three months and one year that
had been reported as odds ratios (ORs) in the published trial. The
complete data were unavailable and there was some inconsistency
between what was provided and the published numbers. These
results have been included in the text of this review, in the form
of the published ORs.
Assessment of risk of bias in included studies
In the first publication of this review three review authors (RFo,
LD, CDM) independently assessed the quality of each of the study
trials that met the inclusion criteria. We resolved disagreements by
consensus. Assessment was blinded (that is, without the knowl-
edge of the study results, the names of the authors, institutions or
journal of publication).
We rated the quality of each eligible RCT according to the ’Risk
of bias’ tool available in RevMan 5.2 and criteria set out in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We assessed methodological quality under the headings of
allocation, blinding, incomplete outcome data, selective reporting
and other potential sources of bias.
Two review authors (LD, CDM) independently assessed the
methodological quality of the trial included in the 2010 update.
We resolved disagreements by discussion.
Measures of treatment effect
We analysed data using RevMan 5.2. We expressed continuous
data comparisons using mean differences (MD) where there was
one study or standardised MD where more than one study used
different measurement scales. We expressed dichotomous data us-
ing odds ratios (OR).We pooled data into clinical outcomes where
multiple trial results for the same clinical presentation existed and
there was no heterogeneity.
Unit of analysis issues
The units of analysis for each outcome are the individual research
participants.
Dealing with missing data
Six studies included an intention-to-treat (ITT) analysis. Three
other studies described their minimal drop-out rates. One study
(El-Daher 1991) did not discuss the drop-out rate, though it was
small.
Assessment of heterogeneity
We did not undertake a meta-analysis for most clinical outcomes
owing to multiple analyses with only one or two study results.
We pooled results where satisfactorily low I2 statistic and non-
significant Chi2 test results were found. We did not undertake a
meta-analysis for antibiotic use owing to the heterogeneity of the
included study results, likely owing to different antibiotic indica-
tions for different clinical presentations.
Assessment of reporting biases
Two studies collected data on clinical outcomes yet did not report
them in detail (Dowell 2001; Gerber 1990). In both cases, the
studies reported that there was no difference between control and
intervention groups.
Data synthesis
Most of the data in this review are reported as a narrative synthesis
describing outcome measures. As indicated previously, we pooled
results where satisfactorily low I2 statistic and non-significant Chi
2 test results were found. We undertook a meta-analysis for the
outcomes of fever for sore throat and patient satisfaction.
Subgroup analysis and investigation of heterogeneity
Subgroup analyses were considered for all outcomes and included
year of publication, clinical presentation, differences in the inter-
vention and risk of bias.
We describe in the results section the two subgroup analyses that
showed differences in outcomes. We explored heterogeneity of
antibiotic use in delayed antibiotic arms further with analysis of
different methods of the delay strategy.We explored heterogeneity
of patients satisfaction further with respect to blinding of outcome
assessor and patient.
R E S U L T S
Description of studies
Results of the search
Searches conducted for this review have resulted in 244 articles
being identified by electronic searching; 28were retrieved formore
detailed evaluation and 17 studies have been formally evaluated.
Five studies were excluded and are described in the Excluded
studies section.Two studies identified in this 2013 update reported
longer-term outcomes from previously included studies (Little
2006; Moore 2009) and while their data have been added to this
review, they are considered part of the original included studies.
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Ten trials were eligible for inclusion. They included 1159 partic-
ipants in their delayed antibiotic arm, with 1067 participants in
the immediate antibiotic arm of nine trials and 465 participants
in the no antibiotic arm of three trials.
In thismost recent update (2013), following removal of duplicated
studies, searches resulted in the identification of 77 articles (out
of the 244 previously mentioned). Five articles were retrieved for
further evaluation (out of 28). Three studies were excluded (out
of a total of five) because they were not randomised. The remain-
ing two reported longer-term outcomes from previously included
studies (Little 2006; Moore 2009) and while their data have been
added to this review, they are considered part of the original in-
cluded studies. Therefore, there are no more included studies as a
result of this 2013 update.
Included studies
Nine trials compared immediate antibiotics with delayed antibi-
otics. Four of these trials investigated acute pharyngitis/sore throat;
two with AOM; two with cough and one dealt with the common
cold. Early studies of sore throat (El-Daher 1991; Gerber 1990;
Pichichero 1987) were designed as efficacy trials to identify the
rate of relapse of groupA beta-haemolytic streptococcus (GABHS)
throat in immediate versus delayed antibiotic groups. Subsequent
trials (Arroll 2002a; Dowell 2001; Little 1997; Little 2001; Spiro
2006) comparing delayed antibiotics and immediate antibiotics
were conducted with a view to evaluate the use of delayed antibi-
otics to reduce the use of antibiotics for upper respiratory tract
infections (RTIs).
Three studies compared the prescribing strategy of no antibiotics
with delayed antibiotics (Chao 2008; Little 1997; Little 2005a).
These three trials investigated the presentations of sore throat (
Little 1997), cough (Little 2005a) and AOM (Chao 2008). This
last trial (Chao 2008) also asked patients in the no antibiotic arm
to return if their symptoms had not resolved.
Excluded studies
Since the first publication of this review, five trials have been ex-
cluded. One because it used a before-and-after study design (Cates
1999) and four because they were not randomised.
Risk of bias in included studies
Summaries of the bias in included studies are provided in Figure
1 and Figure 2.
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Allocation
Eight included studies were adequately randomised using ran-
dom number tables or computer-generated randomisation. In two
studies the method of randomisation was not described (El-Daher
1991; Little 1997). Only four trials described adequate allocation
concealment using opaque envelopes (Arroll 2002a; Little 2001;
Little 2005a; Spiro 2006)
Blinding
Three studies attempted to blind the patient and the doctor with-
out mentioning the outcome assessor (Arroll 2002a; El-Daher
1991; Pichichero 1987). In one study patients were told only that
they would be given one of two sets of instructions about taking
antibiotics for their colds. Participants read an information sheet
and then completed a consent form. Thus, patients were blinded
to what the other group would take (Arroll 2002a). Two studies
used placebo tablets to blind patients (El-Daher 1991; Pichichero
1987). Seven studies attempted to blind some or all aspects of the
study; that is, the patients, the doctor and the outcome assessor.
For four studies (Chao 2008; Dowell 2001; Little 2005a; Spiro
2006), the outcomes assessor was blinded but not the patient or
the care giver. For the remaining three studies no blinding was
undertaken (Gerber 1990; Little 1997; Little 2001).
Incomplete outcome data
Only one trial (El-Daher 1991) had incomplete outcome data and
did not adequately address it.
Selective reporting
Only one trial (Gerber 1990) reported collecting important in-
formation (in this case related to clinical outcomes) without fully
reporting it.
Other potential sources of bias
No other sources of bias were identified.
Effects of interventions
For most outcomes meta-analyses were not possible: some studies
did not describe their data in sufficient detail and others were too
heterogeneous to safely allow meta-analysis. Therefore, few forest
plots have more than one study. Table 1 summarises the statistical
outcomes available for each study. However, for patient satisfac-
tion, data were available and homogenous, so pooled results using
a random-effects model are presented. For sore throat, two trials
with minimal heterogeneity have been pooled for the outcome of
fever severity on day three.
Results are outlined under the headings of clinical outcomes, an-
tibiotic use and patient satisfaction in order to reflect the impor-
tant clinical considerations relevant to the strategy of prescribing
delayed antibiotics. The strategy of delayed antibiotics is compared
to the strategies of immediate antibiotics and no antibiotics, de-
pending on the available data. For each illness category there is at
least one RCT (for example, common cold) with a maximum of
four (sore throat). Given the low numbers of trials for each illness
category, conclusions for illness categories need to be treated with
caution. Themultiplicity of comparisons for the clinical outcomes
stratified by illness, makes a type I error more likely. However,
clinical outcomes are stratified by illness owing to known differ-
ences in the effect of antibiotics on different types of respiratory
infections. Antibiotic use and patient satisfaction data have been
presented without this stratification as they are less likely to be
affected by illness type and to show more clearly the effect of pre-
scribing strategies.
Clinical outcomes
See Table 1.
Sore throat
Four included studies examined sore throat (El-Daher 1991;
Gerber 1990; Little 1997; Pichichero 1987).
Delayed antibiotics versus immediate antibiotics
Pain was reduced on day three in the immediate antibiotic group
compared to delayed antibiotics in one study (Analysis 1.1). Pain
was not significantly different between delayed and immediate
antibiotic groups in three studies (Gerber 1990; Little 1997;
Pichichero 1987).
Malaisewas reduced onday three in the immediate antibiotic group
compared to delayed antibiotics in one study (Analysis 2.1) and no
difference was found in the other study measuring this outcome
(Analysis 2.2).
Fever severity on day three was reduced with immediate antibi-
otics compared to delayed antibiotics in two studies (pooled re-
sults odds ratio (OR) 0.53; 95% confidence interval (CI) 0.31 to
0.74) (Analysis 3.1). The number of days with fever was reduced
in the immediate antibiotic group of Little 1997 and there was no
difference found in the fourth study (Gerber 1990).
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Delayed antibiotics versus no antibiotics
One study examining sore throat compared the prescribing strat-
egy of delayed antibiotics with no antibiotics (Little 1997). This
study found no difference in any clinical outcome between these
two prescribing strategies.
Complications
Data on complications of sore throat such as rheumatic fever, post-
streptococcal glomerulonephritis and peri-tonsillar abscess were
not reported in any of the four studies looking at sore throat for
the three prescribing strategies of immediate, delayed and no an-
tibiotics.
Acute otitis media (AOM)
Three included trials examined AOM (Chao 2008; Little 2001;
Spiro 2006).
Delayed antibiotics versus immediate antibiotics
Pain and malaise were greater using delayed antibiotics compared
to immediate antibiotics in one study measuring these outcomes
on day three (Analysis 4.1).One study examined clinical outcomes
on days four to six and found no difference (Analysis 5.1).
Other proxies for malaise outcomes reported by Little 2001 in-
cluded last day of crying, which favoured the immediate antibiotic
group by approximately 16 hours in children with AOM (0.69
days; 95% CI 0.31 to 0.07). In the same study, just over half a
spoon of paracetamol a day less was used in the immediate an-
tibiotic group (0.59; 95% CI 0.25 to 0.93). On day one there
were no significant differences between immediate and delayed an-
tibiotic groups in symptom outcome measures and by day seven
there was no difference between immediate and delayed antibiotic
groups (Little 2001).
Further analysis of earache from one trial (Little 2001) found the
delayed prescribing strategy did not significantly increase risk of
earache at three months (OR 0.89; 95% CI 0.48 to 1.65) or one
year (OR 1.03; 95% CI 0.60 to 1.78) (Little 2006).
Delayed antibiotics versus no antibiotics
Only one study compared delayed antibiotics with no antibiotics
with no significant difference for pain or fever on day three (
Analysis 8.1; Analysis 9.1). This trial also advised participants in
the no antibiotic arm to re-present in two to three days if symptoms
did not resolve.
Complications
Data on complications of AOM such as mastoiditis, rheumatic
fever and post-streptococcal glomerulonephritis were not reported
in any of the three studies looking at AOM for the prescribing
strategies of immediate and delayed antibiotics. However, Spiro
2006 and Chao 2008 noted that there were no serious adverse
events for participants in the study.
Bronchitis (cough)
Two studies examined the prescribing strategies of immediate
versus delayed antibiotics for the clinical presentation of cough
(Dowell 2001; Little 2005a) and neither found any difference in
clinical outcomes, including fever and cough.
Complications
Little 2005a also looked at delayed antibiotics versus no antibiotics
and found no difference in clinical outcomes between the two
prescribing strategies. One patient in the no antibiotic group (out
of 273) of this study developed pneumonia and recovered with
antibiotics in hospital.
Dowell 2001 did not report on complications in the immediate
and delayed antibiotic groups.
Common cold
One study looked at immediate antibiotics versus delayed antibi-
otics (Arroll 2002a) and found no difference between the two pre-
scribing strategies for the clinical outcomes of fever, cough, pain
and malaise (Analysis 10.1; Analysis 11.4; Analysis 12.1).
Antibiotic use
See Table 1.
Delayed antibiotics
The three studies included in this systematic review published
prior to 1992 examined the concern that immediate antibiotics
for streptococcal pharyngitis might impair the body’s immune
response and predispose the patient to a relapse of pharyngitis.
Compliance in both immediate and delayed antibiotic groups was
close to 100%. Six of the included studies published after 1992
were conducted to evaluate the role of delayed antibiotics as a way
of reducing antibiotic use for respiratory infections compared to
immediate antibiotics. All six studies found that antibiotic use was
significantly reduced in the delayed antibiotic group compared to
the immediate antibiotic group. There were significant differences
in the way antibiotics were delayed which may have resulted in the
marked heterogeneity of this result. Of the seven studies published
after 1991, four had the delayed script kept at reception to be
picked up (Dowell 2001; Little 1997; Little 2001; Little 2005a)
and in three, the script was issued to patients with instructions
to delay (Arroll 2002a; Chao 2008; Spiro 2006). For the delayed
arms of the four studies where the script was left at reception,
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antibiotics were used in 28% of cases (173/618) compared with
antibiotics being used in 40% of cases (122/305) where antibiotics
were issued to patients with instructions to delay.
Overall, the seven trials post 1992 providing a delayed antibi-
otic arm found 295 prescriptions filled out of 923 participants
(32.0%).
Immediate antibiotics
Six trials published post 1992 provided immediate antibiotic arms
examining this outcome resulting in 790 participants filling pre-
scriptions out of 847 participants (93.3%) (Analysis 13.1).
No antibiotics
Three studies compared delayed antibiotics with no antibiotics.
Little 1997 found that there was less antibiotic use with the no
antibiotic strategy compared to delayed antibiotics. Little 2005a
found no differences. Chao 2008 is themost recent and only study
conducted comparing delayed antibiotics only with no antibiotics
and also found that fewer antibiotics were prescribed in the no
antibiotic group (Analysis 15.1).
Overall, 65 patients filled scripts out of 466 participants (13.9%).
Patient satisfaction
See Table 1.
Delayed antibiotics versus immediate antibiotics
(Analysis 16.1)
Patient satisfaction has been measured in five out of seven stud-
ies evaluating the prescribing strategy of delayed antibiotics since
1992 (Arroll 2002a; Dowell 2001; Little 1997; Little 2001; Little
2005a). Two of these studies indicated that study participants were
more satisfied with the strategy of immediate antibiotics than de-
layed antibiotics (Little 2001; Little 2005a). There was no differ-
ence found in the other three studies (Arroll 2002a; Dowell 2001;
Little 1997). The pooled result for this outcome with these five
studies was an odds ratio (OR) of 0.52 (95% CI 0.35 to 0.76)
favouring immediate antibiotics. Fixed- and random-effects analy-
ses gave similar results. A breakdown of the trials by blinding gave
two trials (Dowell 2001; Little 2005a) which blinded the outcome
assessor and one blinded the patient and the doctor (Arroll 2002a)
to give an odds ratio for all three studies of 0.62 (95% CI 0.38
to 1.01). The two completely unblinded trials (Little 1997; Little
2001) give an OR of 0.42 (95% CI 0.22 to 0.78). Overall 92% of
the participants in the immediate antibiotics arms were satisfied
versus 87% in the delayed arms.
Delayed antibiotics versus no antibiotics
(Analysis 17.1)
Three studies examined patient satisfaction comparing the pre-
scribing strategies of delayed antibiotics and no antibiotics (Chao
2008; Little 1997; Little 2005a). While there was no difference in
patient satisfaction for any of these studies, the pooled result for
these three studies was an odds ratio of 1.44 (95%CI 0.99 to 2.10)
showing no statistically significant difference. Fixed- and random-
effects analyses gave similar results. A breakdown of the trials by
blinding gave two trials (Chao 2008; Little 2005a) which blinded
the outcome assessor to give an odds ratio for these two trials of
1.42 (95% CI 0.92 to 2.19). The one completely unblinded trial
(Little 1997) gave an odds ratio of 1.49 (95% CI 0.70 to 3.19).
In the delayed antibiotic arm 413 of the participants were satisfied
or very satisfied out of 473 participants (87.3%) compared to 387
out of 465 participants in the no antibiotics group (83.2%).
Adverse effects of antibiotics
Adverse effects are considered under different clinical headings
owing to differences in antibiotic prescribing recommendations
for each condition. This is likely to have contributed to the het-
erogeneity evident in the forest plots for these outcomes prevent-
ing pooling of results. Adverse results are presented graphically
for delayed versus immediate antibiotics (Analysis 17.1; Analysis
17.2; Analysis 17.3; Analysis 18.4) and delayed versus no antibi-
otics (Analysis 18.1; Analysis 18.2; Analysis 18.3; Analysis 18.4).
Sore throat
Delayed antibiotics versus immediate antibiotics
One study (Little 1997) found no difference for diarrhoea, vomit-
ing, rash and stomach ache. El-Daher 1991 found more vomiting
in the delayed group compared to the immediate antibiotics.
Delayed antibiotics versus no antibiotics
One study (Little 1997) found no difference for diarrhoea, vom-
iting, rash and stomach ache.
AOM
Delayed antibiotics versus immediate antibiotics
Little 2001 and Spiro 2006 found reduced diarrhoea in the delayed
antibiotic group. Spiro 2006 did not find any difference between
delayed and immediate antibiotics for vomiting and Little 2001
found no difference for the outcome of rash.
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Delayed antibiotics versus no antibiotics
There were no adverse events in either group reported by Chao
2008.
Bronchitis (cough)
Delayed antibiotics versus immediate antibiotics
Little 2005a found no difference for adverse effects.
Delayed antibiotics versus no antibiotics
Little 2005a found no difference for adverse effects.
Common cold
Delayed antibiotics versus immediate antibiotics
There was no significant difference between the groups for diar-
rhoea, a potential adverse effect of antibiotics (Arroll 2002a).
Re-consultation rates
Re-consultation rates were the same between delayed and im-
mediate antibiotic groups in two studies (Analysis 19.1). Subse-
quent consultation rates in the 12 months (excluding the first
month) were also the same between delayed and immediate an-
tibiotic groups in one study (Little 2001). Participants with sore
throat in one study were more likely to intend to consult again
if they received immediate antibiotics compared to delayed antibi-
otics (Little 1997).
D I S C U S S I O N
Summary of main results
Small differences were found between prescribing strategies for
clinical outcomes with immediate antibiotics most likely to show
benefit over delayed antibiotics in participants with sore throat and
acute otitis media (AOM). All strategies appear to have similar
safety with no advantage found for delayed antibiotics over no an-
tibiotics for disease complications. Delay and no antibiotic strate-
gies dramatically reduce the use of antibiotics for acute respiratory
tract infections (ARTIs) compared to immediate antibiotics. The
least antibiotic use was in the no antibiotic group followed by delay
and then immediate. The number needed to treat to prevent one
antibiotic prescription using the delay strategy is 1.6 compared to
immediate antibiotics. The number needed to treat to prevent one
antibiotic prescription using a no antibiotic strategy compared to
delay is 5.6. Patient satisfaction was highest in the immediate an-
tibiotic group with 92.2% being satisfied or very satisfied with the
consultation. The delay and no groups had similar quite high sat-
isfaction rates at 87.3% and 83.2%, respectively. These high sat-
isfaction results may reflect patient involvement in studies where
their treating physicians are more thorough in their explanations
than usual (Hawthorne effect) (French 1950; Levitt 2011). Results
for satisfaction may not be as high in routine general practice.
Overall completeness and applicability of
evidence
Studies comparing delayed and immediate antibiotics have been
performed for two different motives. The studies of Pichichero
1987, Gerber 1990 and El-Daher 1991 were concerned that im-
mediate antibiotics for streptococcal pharyngitis might impair the
body’s immune response and predispose the patient to a relapse
of pharyngitis. These studies are useful for determining the effect
of delayed versus immediate antibiotics on the clinical course of
suspected streptococcal pharyngitis. Six of the remaining studies
were conducted to determine if the strategy of delayed antibiotics
reduces the number of prescriptions filled for upper ARTIs (Arroll
2002a; Dowell 2001; Little 1997; Little 2001) while maintaining
patient safety and satisfaction. The most recent study may indi-
cate evolution in prescribing habits as it was the first to drop the
immediate antibiotic arm (Chao 2008).
Useful data were collected for many symptom outcomes in all
studies but were not always reported in a way that could be anal-
ysed. This problem was partially overcome by obtaining raw data
from some trial authors. The seven studies conducted after 1992
all reported useful data on antibiotic use and six on patient satis-
faction.
There are only three trials comparing delayed antibiotics with no
antibiotics.
Quality of the evidence
All but one trial (El-Daher 1991) were adequately randomised
and accounted for incomplete data. El-Daher 1991 did find large
differences for clinical outcomes for sore throat in favour of im-
mediate antibiotics compared to delayed antibiotics.
This intervention does not lend itself to blinding. However, three
trials attempted to blind patients and doctors (Arroll 2002a; El-
Daher 1991; Pichichero 1987). For four studies (Chao 2008;
Dowell 2001; Little 2005a; Spiro 2006), the outcomes assessor
was blinded but not the patient nor the care giver.
Otherwise, studies were well reported and appeared to be high
quality.
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Potential biases in the review process
Heterogeneity of randomised controlled trials (RCTs) is one lim-
itation of this review. Heterogeneity may have resulted from vari-
able clinical presentations, differences in delaymethod, differences
in antibiotic use and quality of included studies. Potential for type
I error is another limitation of this review given the large num-
ber of reported outcome results. For example, multiple outcome
measures are reported for the clinical outcomes comparing delayed
and immediate antibiotic groups.
Agreements and disagreements with other
studies or reviews
Findings for certain clinical outcomes in our review might have
been anticipated. Systematic reviews on antibiotics for sore throat
and AOM found that their time of greatest benefit for symptoms
is apparent at days three or four after treatment has started (Spinks
2011; Venekamp 2013). Thus delaying antibiotics by 48 hours
or more would overshoot this zenith. Nor is it surprising that
we found more adverse reactions to antibiotics from immediate
antibiotics in line with known adverse events from comparison
RCTs with no antibiotics.
The greatest difference in clinical outcomes was found in the only
trial of delayed antibiotics conducted in a low socio-economic en-
vironment, favouring immediate antibiotics over delay (El-Daher
1991). This trial was also the least methodologically sound but it
highlighted that concerns expressed about delayed antibiotics for
children, the elderly (Datta 2008) and those with language or cul-
tural difficulties (Johnson 2007) may also need to be extended to
low socio-economic populations.
A parallel RCT of patients with acute infective conjunctivitis sim-
ilarly reported shortest symptom duration with immediate, fol-
lowed by delayed and then no antibiotics (the last resulting in least
antibiotic use). There was no difference between the groups for
patient satisfaction (Everitt 2006).
A recent randomised controlled trial published in 2010 (Worrall
2010) comparing delayed prescriptions dated either the day of
the office visit or two days later, but not comparing with either
immediate orno antibiotics, demonstratedno significant difference
between the two groups in terms of antibiotic use.
RCTs comparing delayed with no antibiotics (concluding that they
were both equally acceptable alternatives to immediate antibiotics
as a means of reducing antibiotic prescriptions) (Little 2001; Little
2005a) led to recommending delayed instead of no antibiotics to
address concerns about risks of complications (Little 2005b).Doc-
tors worried about the risk of serious infective complications con-
sequent to adopting a no antibiotic rather than delayed strategy
might take comfort from a UK observational study showing that
reduced prescribing resulted in no increase in admissions to hos-
pital for peri-tonsillar abscess or rheumatic fever (Sharland 2005),
although mastoiditis might be a risk at the rate of 2500 children
needing to be treated with antibiotics to prevent one case (Van
Zuijlen 2001). Thirty-five per cent of parents in the AOM trials
(Chao 2008; Little 2001; Spiro 2006) used their delayed script
suggesting that the number of delayed scripts required to prevent
one case of mastoiditis would be significantly higher than 2500.
Doctors often find it difficult to identify patients at risk of serious
complications from respiratory infections (Kumar 2003). Patients
probably perform even less well, despite their self confidence in
making this decision if given a delayed antibiotic prescription. This
concern is supported by empirical data: respiratory disease severity
does not correlate with patients’ immediate preference for an an-
tibiotic prescription (Macfarlane 1997). This review did not find
any significant difference for complication rates between prescrib-
ing strategies.
There is little controversy within published guidelines that imme-
diate antibiotics are recommended for patients who appear to be
seriously unwell, fit multiple criteria indicating bacterial tonsilli-
tis, are under six months of age with AOM, have bilateral AOM
or have AOM with otorrhoea (Tan 2008). American guidelines
also recommend immediate antibiotics for children under twowith
definite AOM (OMTG 2004). It seems then that for the majority
of respiratory infections that do not meet these criteria, clinicians
have the option of delayed or no antibiotics. It seems clear that
no antibiotics will result in least antibiotic use and therefore less
antibiotic resistance. Concerns about patient and doctor satisfac-
tion with no antibiotics appear to be driving the use of a delayed
strategy. Some doctors use the delay strategy to reduce antibiotic
use, empower patients and save the patient time and money with-
out jeopardising the doctor-patient relationship (Arroll 2002b).
A qualitative study conducted in 2002 (Arroll 2002b) found that
while some patients appreciated the option of controlling the de-
cision as to whether and when to take antibiotics, others expected
“the physician to decide”. Concern was expressed by one physician
that patients might view delayed prescribing as physician incom-
petence, substantiated by comments from some patients. Shared
decision-making (Butler 2001; Legare 2007) and education cam-
paigns for doctors (Sung 2006) have been proposed as ways of
helping doctors and patients avoid unnecessary antibiotic use.One
suggestion is that delayed antibiotics may in time become redun-
dant as doctors and their patients gain more reassurance in the
safety of not using antibiotics (Arroll 2003b).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
A strategy of immediate antibiotics is more likely to confer the
modest benefits of antibiotics on clinical outcomes such as symp-
toms for acute otitismedia and sore throat than delayed antibiotics.
There were no differences in complication rates between immedi-
ate and delayed antibiotics nor between delayed and no antibiotics.
12Delayed antibiotics for respiratory infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Immediate antibiotics had slightly higher levels of patient satisfac-
tion than delayed antibiotics, which reached statistical significance
but is of marginal clinical significance (92% versus 87%). Patient
satisfaction was similarly high in the delayed and no antibiotic
groups with a trend towards delayed antibiotics that was neither
statistically nor clinically significant (87% versus 83%). Delayed
antibiotic prescribing strategies achieved lower rates of antibiotic
use compared to immediate antibiotics (32% versus 93%). No an-
tibiotics achieved lower rates of antibiotic use compared to delayed
antibiotics (13% versus 32%).
Delayed antibiotics for respiratory infections is a strategy which
reduces antibiotic use compared to immediate antibiotics but has
not been shown by this review to be different to no antibiotics
in terms of symptom control and disease complications. In pa-
tients with respiratory infections where clinicians feel it is safe not
to prescribe antibiotics immediately, no antibiotics with advice to
return if symptoms do not resolve is likely to result in the least
antibiotic use, while maintaining similar patient satisfaction and
clinical outcomes to delayed antibiotics.
Implications for research
Further research into antibiotic prescribing strategies for respira-
tory infections may best be focused on identifying patient groups
at high risk of disease complications, enhancing doctors’ commu-
nication with patients to maintain satisfaction and ways of reduc-
ing doctors’ anxieties about not prescribing antibiotics for respi-
ratory infections. Future randomised controlled trials of delaying
antibiotics as an intervention should fully report symptoms, pa-
tient satisfaction, doctor satisfaction and disease complications as
well as changes in prescription rates. They should also include a
no antibiotic arm.
A C K N OW L E D G E M E N T S
The review authors wish to thank the following people for com-
menting on the 2010 updated review: Alison Thomas, Bill Hue-
ston, Max Bulsara and Tom Fahey. We also thank the following
people for commenting on this 2013 updated review: Amanda
Roberts, Sandra Arnold, Bill Hueston, Sree Nair and Tom Fahey.
R E F E R E N C E S
References to studies included in this review
Arroll 2002a {published and unpublished data}
Arroll B, Kenealy T, Kerse N. Do delayed prescriptions
reduce the use of antibiotics for the common cold? A single-
blind controlled trial. Journal of Family Practice 2002;51(4):
324–8.
Chao 2008 {published data only (unpublished sought but not used)}
Chao J, Kunkov S, Reyes L, Lichten S, Crain E. Comparison
of two approaches to observation therapy for acute otitis
media in the emergency department. Pediatrics 2008;121
(5):1352–6.
Dowell 2001 {published data only}
Dowell J, Pitkethy M, Bain J, Martin S. A randomised
controlled trial of delayed antibiotic prescribing as a strategy
for managing uncomplicated respiratory tract infection in
primary care. British Journal of General Practice 2001;51
(464):200–5.
El-Daher 1991 {published data only}
El-Daher N, Rawashedeh N, Al-Khalil I, Abu-ektaish
F. Immediate versus delayed treatment of group A beta-
haemolytic streptococcal pharyngitis with penicillin V.
Pediatric Infectious Disease Journal 1991;10(2):126–30.
Gerber 1990 {published data only}
Gerber M, Randolph M, DeMeo K, Kaplan E. Lack
of impact of early antibiotic therapy for streptococcal
pharyngitis on recurrence rates. Journal of Pediatrics 1990;
117(6):853–8.
Little 1997 {published data only}
Little P, Williamson I, Warner G, Gould C, Gantley M,
Kinmonth AL. Open randomised trial of prescribing
strategies in managing sore throat. BMJ 1997;314(7082):
722–7.
Little 2001 {published and unpublished data}
∗ Little P, Gould C, Williamson I, Moore M, Warner G,
Dunleavey J. Pragmatic randomised controlled trial of two
prescribing strategies for childhood acute otitis media. BMJ
2001;322(7282):336–42.
Little P, Moore M, Warner G, Dunleavy J, Williamson
I. Longer term outcomes from a randomised trial of
prescribing strategies in otitis media. British Journal of
General Practice 2006;56(524):176–82.
Little 2005a {published data only}
∗ Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner
G, et al. Information leaflet and antibiotic prescribing
strategies for acute lower respiratory infection. JAMA 2005;
293(24):3029–35.
Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner
G, et al. Effect of antibiotic prescribing strategies and an
information leaflet on longer-term reconsultation for acute
lower respiratory tract infection. British Journal of General
Practice 2009;59(567):728–34.
Pichichero 1987 {published data only}
Pichichero M, Disney F, Talpey W, Green J, Francis
A, Roghmann K, et al. Adverse and beneficial effects
of immediate treatment of group A beta-haemolytic
13Delayed antibiotics for respiratory infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
streptococcal pharyngitis with penicillin. Pediatric Infectious
Disease Journal 1987;6(7):635–43.
Spiro 2006 {published data only}
Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD,
Shapiro ED. Wait-and-see prescription for the treatment of
acute otitis media: a randomized controlled trial. JAMA
2006;296(10):1235–41.
References to studies excluded from this review
Cates 1999 {published data only}
Cates C. An evidence based approach to reducing antibiotics
use in children with acute otitis media: controlled before
and after study. BMJ 1999;318:715–6.
Fischer 2009 {published data only}
Fischer T, Singer A, Chale S. Observation option for acute
otitis media in the emergency department. Paediatric
Emergency Care 2009;25(9):575–8.
Newson 2009 {published data only}
Newson L. Delayed prescribing. Practice Nurse 2009;37(2):
21.
Siegel 2003 {published data only}
∗ Siegel R, Kiely M, Bien JP, Joseph EC, Davis JB, Mendel
SG, et al. Treatment of otitis media with observation and a
safety-net antibiotic prescription. Pediatrics 2003;112(3):
527–31.
Vouloumanou 2009 {published data only}
Vouloumanou E, Karageorgopoulos D, Kazanti M,
Kapaskelis A, Falagas M. Antibiotics versus placebo or
watchful waiting for acute otitis media: a meta-analysis
of randomized controlled trials. Journal of Antimicrobial
Chemotherapy 2009;64(1):16–24.
Additional references
Arason 1996
Arason A, Kristinsson KG, Sigurdson JA, Stefansdottir G,
Molstad S, Gudmundsson S. Do antimicrobials increase the
carriage rate of penicillin resistant pneumoccci in children?
Cross sectional prevalence study. BMJ 1996;313:387–91.
Arroll 2002b
Arroll B, Goodyear-Smith F, Thomas D, Kerse N. Delayed
antibiotic prescriptions: what are the experiences and
attitudes of physicians and patients?. Journal of Family
Practice 2002;51(11):954–9.
Arroll 2003a
Arroll B, Kenealy T, Kerse N. Do delayed prescriptions
reduce antibiotic use in respiratory tract infections? A
systematic review. British Journal of General Practice 2003;
53:871–7.
Arroll 2003b
Arroll B, Kenealy T, Goodyear-Smith F, Kerse N. Delayed
prescriptions. BMJ 2003;327(7428):1361–2.
Arroll 2010
Arroll B, Kenealy T. Antibiotics for the common cold
and acute purulent rhinitis. Cochrane Database of
Systematic Reviews 2010, Issue 2. [DOI: 10.1002/
14651858.CD000247.pub2]
Berman 1997
Berman S, Byrns PJ, Bondy J, Smith PJ, Lezotte D. Otitis
media-related antibiotic prescribing patterns, outcomes, and
expenditures in a pediatric medicaid population. Pediatrics
1997;100(4):585–92.
Brook 1998
Brook I. Microbiology of common infections in the upper
respiratory tract. Primary Care 1998;25(3):633–48.
Butler 2001
Butler CC, Kinnersley P, Prout H, Rollnick S, Edwards
A, Elwyn G. Antibiotics and shared decision-making in
primary care. Journal of Antimicrobial Chemotherapy 2001;
48(3):435–40.
Datta 2008
Datta M. Review: delayed or immediate prescriptions of
antibiotics have similar clinical outcomes in respiratory
infections. Evidence Based Medicine 2008;13(2):42.
Dickersin 1994
Dickersin K, Scherer R, Lefebvre C. Identifying relevant
studies for systematic reviews. BMJ 1994;309(6964):
1286–91.
Everitt 2006
Everitt H, Little P, Smith P. A randomised controlled trial of
management strategies for acute infective conjunctivitis in
general practice. BMJ 2006;333(7563):321.
French 1950
French JRP. Field experiments: changing group productivity.
In: Miller JG editor(s). Experiments in Social Process: A
Symposium on Social Psychology. McGraw-Hill, 1950:82.
Higgins 2011
Higgins JPT. Chapter 8: Assessing risk of bias in included
studies. In: Higgins JPT, Green S editor(s). Cochrane
Handbook for Systematic Reviews of Interventions. Version
5.1.0. The Cochrane Collaboration [updated March 2011].
Chichester, UK: Wiley-Blackwell, 2011.
Johnson 2007
Johnson NC, Holger JS. Pediatric acute otitis media: the
case for delayed antibiotic treatment. Journal of Emergency
Medicine 2007;32(3):279–84.
Kumar 2003
Kumar S, Little P, Britten N. Why do general practitioners
prescribe antibiotics for sore throat?. BMJ 2003;326(7392):
138–43.
Legare 2007
Legare F, Labrecque M, Leblanc A, Thivierge R, Godin
G, Laurier C, et al. Does training family physicians in
shared decision making promote optimal use of antibiotics
for acute respiratory infections? Study protocol of a pilot
clustered randomised controlled trial. BMC Family Practice
2007;8:65.
Levitt 2011
Levitt SD, List JA. Was there really a Hawthorne Effect
at the Hawthorne Plant? An analysis of the original
14Delayed antibiotics for respiratory infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
illumination experiments. American Economic Journal:
Applied Economics 2011;3(1):224–38.
Little 2005b
Little P. Delayed prescribing of antibiotics for upper
respiratory tract infection. BMJ 2005;331(7512):301–2.
Little 2006
Little P, Moore M, Warner G, Dunleavy J, Williamson
I. Longer term outcomes from a randomised trial of
prescribing strategies in otitis media. British Journal of
General Practice 2006;56(524):176–82.
Macfarlane 1997
Macfarlane J, HolmesW,Macfarlane R, Britten N. Influence
of patient’s expectations on antibiotic management of
acute lower respiratory tract illness in general practice:
questionnaire study. BMJ 1997;315:1211–4.
Moore 2009
Moore M, Little P, Rumsby K, Kelly J, Watson L, Warner
G, et al. Effect of antibiotic prescribing strategies and an
information leaflet on longer-term reconsultation for acute
lower respiratory tract infection. British Journal of General
Practice 2009;59(567):728–34.
Niemela 1999
Niemela M, Uhari M, Mottonen M, Pokka T. Costs arising
from otitis media. Acta Paediatrica 1999;88(5):553–6.
OMTG 2004
Otitis Media Treatment Guidelines. Diagnosis and
management of acute otitis media. Pediatrics 2004;113(5):
1451–65.
RevMan 5.2 [Computer program]
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). Version 5.2. Copenhagen:
The Nordic Cochrane Centre, The Cochrane Collaboration,
2012.
Sharland 2005
Sharland M, Kendall H, Yeates D, Randall A, Hughes G,
Glasziou P, et al. Antibiotic prescribing in general practice
and hospital admissions for peritonsillar abscess, mastoiditis
and rheumatic fever in children: time trend analysis. BMJ
2005;331(7512):328–9.
Smith 2011
Smith SM, Fahey T, Smucny J, Becker LA.
Antibiotics for acute bronchitis. Cochrane Database of
Systematic Reviews 2011, Issue 11. [DOI: 10.1002/
14651858.CD000245.pub2]
Spinks 2011
Spinks A, Glasziou PP, Del Mar C. Antibiotics for sore
throat. Cochrane Database of Systematic Reviews 2011, Issue
9. [DOI: 10.1002/14651858.CD000023.pub3]
Sung 2006
Sung L, Arroll J, Arroll B, Goodyear-Smith F, Kerse N,
Norris P. Antibiotic use for upper respiratory tract infections
before and after a education campaign as reported by general
practitioners in New Zealand. New Zealand Medical Journal
2006;119(1233):U1956.
Tan 2008
Tan T, Little P, Stokes T. Antibiotic prescribing for self
limiting respiratory tract infections in primary care:
summary of NICE guidance. BMJ 2008;337:a437.
Van Zuijlen 2001
Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AQ.
National differences in incidences of acute mastoiditis:
relationship to prescribing patterns for acute otitis media.
Pediatric Infectious Disease 2001;20:140–4.
Venekamp 2013
Venekamp RP, Sanders S, Glasziou PP, Del Mar CB,
Rovers MM. Antibiotics for acute otitis media in children.
Cochrane Database of Systematic Reviews 2013, Issue 1.
[DOI: 10.1002/14651858.CD000219.pub3]
Verkatesum 1995
Verkatesum P, Innes JA. Antibiotic resistance in common
acute respiratory pathogens. Thorax 1995;50:481–3.
Worrall 2010
Worrall G, Kettle A, Graham W, Hutchinson J. Postdated
versus usual delayed antibiotic prescriptions in primary care.
Canadian Family Physician 2010;56:1032–6.
References to other published versions of this review
Spurling 2007
Spurling GKP, Del Mar CB, Dooley L, Foxlee R. Delayed
antibiotics for symptoms and complications of respiratory
infections. Cochrane Database of Systematic Reviews 2007,
Issue 2. [DOI: 10.1002/14651858.CD004417.pub2]
Spurling 2010
Spurling GKP, Del Mar CB, Dooley L, Foxlee R. Delayed
antibiotics for respiratory infections. Cochrane Database
of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/
14651858.CD004417.pub2]
∗ Indicates the major publication for the study
15Delayed antibiotics for respiratory infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Arroll 2002a
Methods Randomised controlled trial
Participants Adults and children with the common cold
Interventions Delayed antibiotics (patients given script and instructed to fill within 72 hours) versus
immediate antibiotics
Outcomes Fever, duration of fever, cough, duration of cough, pain, absence from school/work,
diarrhoea, antibiotic use
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation using Excel
Allocation concealment (selection bias) Low risk Yes - opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Patient and care provider were blinded but unsure re-
garding outcome assessor
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis used
Selective reporting (reporting bias) Low risk Pre-specified outcomes were reported
Other bias Low risk No information
Chao 2008
Methods Randomised controlled trial
Participants Children with AOM
Interventions No antibiotics (observation) versus delayed antibiotics (observation plus prescription) -
patients given script and instructed to fill the script if required
Outcomes Fever, pain, antibiotic use, patient satisfaction, adverse events
Notes
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Chao 2008 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table
Allocation concealment (selection bias) High risk Not described
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessor blinded. Patient and care provider not
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data were described and ITT analysis applied
Selective reporting (reporting bias) Low risk Pre-specified outcomes were reported
Other bias Low risk No Information
Dowell 2001
Methods Randomised controlled trial
Participants Adults and children with cough
Interventions Delayed antibiotics (script left at reception and patients instructed to pick up the script
after 1 week of delay) versus immediate antibiotics (antibiotic of GP’s choice)
Outcomes Duration of cough, antibiotic use
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table
Allocation concealment (selection bias) Unclear risk Numbered envelopes (opacity not mentioned)
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessor blinded but not patient nor care
provider
Incomplete outcome data (attrition bias)
All outcomes
Low risk Drop-out numbers were described and intention-to-treat
analysis used
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Dowell 2001 (Continued)
Selective reporting (reporting bias) Low risk Pre-specified clinical outcomes were not published but
authors provided this information
Other bias Low risk No Information
El-Daher 1991
Methods Randomised controlled trial
Participants Children with sore throat (suspected group A beta haemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin V 50,000 IU/kg/
day)
Outcomes Pain, malaise, vomiting, temperature
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not described
Allocation concealment (selection bias) High risk Not described
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of patient and care provider but unsure about
outcome assessor
Incomplete outcome data (attrition bias)
All outcomes
High risk Drop-outs not described
Selective reporting (reporting bias) Low risk Pre-specified outcomes reported
Other bias Low risk No Information
Gerber 1990
Methods Randomised controlled trial
Participants Adults and children with sore throat (suspected group A beta haemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin V, 250 mg qds for
10 days)
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Gerber 1990 (Continued)
Outcomes Malaise
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table
Allocation concealment (selection bias) High risk No Information
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Drop outs described
Selective reporting (reporting bias) Unclear risk Clinical outcomes reported as one outcome
Other bias Low risk No Information
Little 1997
Methods Open randomised controlled trial
Participants Adults and children with sore throat
Interventions Delayed antibiotics (script left at reception and patients instructed to pick it up 72 hours
later if required) versus immediate antibiotics versus no antibiotics (penicillin V 250 mg
qds in both groups)
Outcomes Fever, cough, duration of pain, duration of malaise, absence from school, diarrhoea and
rash
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomisation method not described
Allocation concealment (selection bias) Unclear risk “Sealed envelopes”; no mention of opacity
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Little 1997 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
High risk No Information
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis undertaken
Selective reporting (reporting bias) Low risk No Information
Other bias Low risk No Information
Little 2001
Methods Pragmatic randomised controlled trial
Participants Children aged 6 months to 10 years with AOM
Interventions Delayed antibiotics (72 hours, parents were advised to use antibiotics if their child had
significant otalgia or fever after 72 hours, or if discharge lasted for 10 days or more)
versus immediate antibiotics (amoxicillin 250 mg tds for 1 week)
Outcomes Fever, severity of pain, duration of malaise, absence from school, use of paracetamol,
antibiotic use, further earache at 3 and 12 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “patients were randomised to a group”
Allocation concealment (selection bias) Low risk Quote: “doctor opened a sealed numbered
opaque envelope”
Blinding (performance bias and detection
bias)
All outcomes
High risk No blinding undertaken
Incomplete outcome data (attrition bias)
All outcomes
Low risk A comparison of responders versus non-re-
sponders was undertaken
Selective reporting (reporting bias) Low risk Pre-specified outcomes have been reported
Other bias Low risk No Information
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Little 2005a
Methods Randomised controlled trial
Participants Adults and children aged 3 years and over with cough and at least 1 symptom or sign
localising to the lower respiratory tract
Interventions Delayed antibiotics (script left at reception and patients instructed to pick up the script
after 14 days if required) versus immediate antibiotics versus no antibiotics
Outcomes Fever, cough, duration of cough, severity of cough, malaise, duration of malaise, compli-
cations of disease, hospital admissions, diarrhoea, antibiotic use, re-consultation in the
12 months following the index consultation, excluding the first month after the index
consultation
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number tables and block
randomisation (block size 6)
Allocation concealment (selection bias) Low risk Opaque sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessor was blinded. Patient and care provider
were not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data were described and intention-to-treat anal-
ysis used
Selective reporting (reporting bias) Low risk Pre-specified outcomes were reported
Other bias Low risk No Information
Pichichero 1987
Methods Open randomised controlled trial
Participants Children with sore throat (suspected group A beta haemolytic Streptococcus)
Interventions Delayed antibiotics (48 hours) versus immediate antibiotics (penicillin 250 mg tds for 10
days)
Outcomes Fever, duration of fever, malaise, re-consultation rates, vomiting
Notes
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Pichichero 1987 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers
Allocation concealment (selection bias) High risk Not used
Blinding (performance bias and detection
bias)
All outcomes
Low risk Patient and doctor blinded but unsure about out-
come assessor
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Pre-specified outcomes were reported
Other bias Low risk No Information
Spiro 2006
Methods Placebo and randomised controlled trial
Participants Children aged 6 months to 12 years
Interventions Delayed antibiotics (patients given a script which was to expire after 72 hours) versus
immediate antibiotics
Outcomes Fever, duration of fever, pain, duration of pain, vomiting, diarrhoea, rash, antibiotic use
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-assisted randomisation
Allocation concealment (selection bias) Low risk Sealed opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
High risk Study participants were not blinded but out-
come assessors were blinded
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Spiro 2006 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk More people in the wait and see prescription
group stayed in the trial, however this was
acknowledged and addressed
Selective reporting (reporting bias) Low risk Pre-specified outcomes were reported
Other bias Low risk No Information
AOM: acute otitis media
ITT: intention-to-treat
IU: international units
qds: four times a day
tds: three times a day
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cates 1999 Not a randomised controlled trial
Fischer 2009 Not a randomised controlled trial
Newson 2009 Not a randomised controlled trial
Siegel 2003 Not a randomised controlled trial
Vouloumanou 2009 Not a randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Sore throat - pain; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain severity on day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 2. Sore throat - malaise; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaise on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Malaise severity 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 3. Sore throat - fever; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever severity on day 3 2 343 Std. Mean Difference (IV, Fixed, 95% CI) 0.53 [0.31, 0.74]
2 Fever severity on day 1 2 343 Std. Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.29, 0.14]
Comparison 4. AOM - pain; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain on days 4 to 6 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Pain on day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Pain severity on day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Pain severity on day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Comparison 5. AOM - malaise; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Malaise on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Malaise severity on day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Malaise severity on day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 6. Supplementary medicine consumption; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Spoons of paracetamol/day 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Use of paracetamol and
ibuprofen
1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 7. AOM - fever; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever Days 4 to 6 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 8. AOM - pain; delayed versus no antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Otitis media pain on Day 3
delayed versus none
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
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Comparison 9. AOM - fever; delayed versus no antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Otitis media number of patients
with fever on day 3 delayed
versus none
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
Comparison 10. Common cold - pain; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pain on day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 11. Common cold - fever; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Fever on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Fever on day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Fever severity on day 1 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Fever severity on day 3 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5 Fever severity on day 7 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 12. Common cold - cough; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cough on day 3 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Cough on day 7 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 13. Antibiotic use: delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic use: delayed versus
immediate antibiotics
6 Odds Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Antibiotic use: delayed
(prescription at time of visit)
versus immediate antibiotics
2 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Antibiotic use: delayed
(return for prescription) versus
immediate antibiotics
4 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 14. Antibiotic use: delayed versus no antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic use: delayed versus no
antibiotics
3 Odds Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Antibiotic use: delayed
(prescription at time of visit)
versus no antibiotics
1 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Antibiotic use: delayed
(return for prescription) versus
no antibiotics
2 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 15. Patient satisfaction: delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient satisfaction: delayed
versus immediate antibiotics
5 1334 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.35, 0.76]
1.1 Patient satisfaction:
delayed (prescription at time
of consult) versus immediate
antibiotics
1 129 Odds Ratio (M-H, Random, 95% CI) 1.47 [0.32, 6.85]
1.2 Patient satisfaction:
delayed (return for
prescription) versus immediate
antibiotics
4 1205 Odds Ratio (M-H, Random, 95% CI) 0.48 [0.33, 0.71]
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Comparison 16. Patient satisfaction: delayed versus no antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient satisfaction: delayed
versus no antibiotics
3 938 Odds Ratio (M-H, Random, 95% CI) 1.44 [0.99, 2.10]
1.1 Patient satisfaction:
delayed (prescription provided
at visit) versus no antibiotics
1 206 Odds Ratio (M-H, Random, 95% CI) 2.00 [0.65, 6.18]
1.2 Patient satisfaction:
delayed (return for prescription)
versus no antibiotics
2 732 Odds Ratio (M-H, Random, 95% CI) 1.38 [0.93, 2.06]
Comparison 17. Adverse events: delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Vomiting 3 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2 Diarrhoea 4 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Rash 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Stomach ache 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 18. Adverse events: delayed versus no antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Vomiting 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Diarrhoea 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Rash 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Stomach ache 1 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
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Comparison 19. Re-consultation rate; delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Re-consultation rate 2 379 Odds Ratio (M-H, Fixed, 95% CI) 1.04 [0.55, 1.98]
Comparison 20. Subsequent consultation rates in the 12 months following the index consultation (excluding first
month following consultation); delayed versus immediate antibiotics
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Re-consultation in the 12
months following the index
consultation (excluding the
first month following the index
consultation)
1 Rate Ratio (Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Sore throat - pain; delayed versus immediate antibiotics, Outcome 1 Pain on
day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 1 Sore throat - pain; delayed versus immediate antibiotics
Outcome: 1 Pain on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El-Daher 1991 106/118 42/111 14.51 [ 7.14, 29.50 ]
0.01 0.1 1 10 100
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 1.2. Comparison 1 Sore throat - pain; delayed versus immediate antibiotics, Outcome 2 Pain
severity on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 1 Sore throat - pain; delayed versus immediate antibiotics
Outcome: 2 Pain severity on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pichichero 1987 55 1.6 (1.38) 59 1.3 (1) 0.30 [ -0.15, 0.75 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 2.1. Comparison 2 Sore throat - malaise; delayed versus immediate antibiotics, Outcome 1 Malaise
on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 2 Sore throat - malaise; delayed versus immediate antibiotics
Outcome: 1 Malaise on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
El-Daher 1991 45/118 4/111 16.49 [ 5.68, 47.83 ]
0.005 0.1 1 10 200
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 2.2. Comparison 2 Sore throat - malaise; delayed versus immediate antibiotics, Outcome 2 Malaise
severity.
Review: Delayed antibiotics for respiratory infections
Comparison: 2 Sore throat - malaise; delayed versus immediate antibiotics
Outcome: 2 Malaise severity
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pichichero 1987 55 1.3 (1) 59 1.1 (0.67) 0.20 [ -0.11, 0.51 ]
-10 -5 0 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 3.1. Comparison 3 Sore throat - fever; delayed versus immediate antibiotics, Outcome 1 Fever
severity on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 3 Sore throat - fever; delayed versus immediate antibiotics
Outcome: 1 Fever severity on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
El-Daher 1991 118 38 (1.96) 111 37.1 (0.95) 66.4 % 0.58 [ 0.31, 0.84 ]
Pichichero 1987 55 37.2 (1.17) 59 36.8 (0.61) 33.6 % 0.43 [ 0.06, 0.80 ]
Total (95% CI) 173 170 100.0 % 0.53 [ 0.31, 0.74 ]
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 4.80 (P < 0.00001)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 3.2. Comparison 3 Sore throat - fever; delayed versus immediate antibiotics, Outcome 2 Fever
severity on day 1.
Review: Delayed antibiotics for respiratory infections
Comparison: 3 Sore throat - fever; delayed versus immediate antibiotics
Outcome: 2 Fever severity on day 1
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
El-Daher 1991 118 38.7 (0.65) 111 38.8 (0.53) 66.7 % -0.17 [ -0.43, 0.09 ]
Pichichero 1987 55 38.2 (0.83) 59 38.1 (0.89) 33.3 % 0.12 [ -0.25, 0.48 ]
Total (95% CI) 173 170 100.0 % -0.07 [ -0.29, 0.14 ]
Heterogeneity: Chi2 = 1.52, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours delayed antibiotics Favours immediate antibiotics
Analysis 4.1. Comparison 4 AOM - pain; delayed versus immediate antibiotics, Outcome 1 Pain on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; delayed versus immediate antibiotics
Outcome: 1 Pain on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 28/111 15/101 1.93 [ 0.96, 3.88 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
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Analysis 4.2. Comparison 4 AOM - pain; delayed versus immediate antibiotics, Outcome 2 Pain on days 4 to
6.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; delayed versus immediate antibiotics
Outcome: 2 Pain on days 4 to 6
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 85/132 89/133 0.89 [ 0.54, 1.48 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 4.3. Comparison 4 AOM - pain; delayed versus immediate antibiotics, Outcome 3 Pain on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; delayed versus immediate antibiotics
Outcome: 3 Pain on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 3/111 0/101 6.55 [ 0.33, 128.35 ]
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Analysis 4.4. Comparison 4 AOM - pain; delayed versus immediate antibiotics, Outcome 4 Pain severity on
day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; delayed versus immediate antibiotics
Outcome: 4 Pain severity on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 111 2.56 (2.14) 102 1.81 (1.44) 0.75 [ 0.26, 1.24 ]
-10 -5 0 5 10
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Analysis 4.5. Comparison 4 AOM - pain; delayed versus immediate antibiotics, Outcome 5 Pain severity on
day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 4 AOM - pain; delayed versus immediate antibiotics
Outcome: 5 Pain severity on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 111 1.17 (0.75) 101 1.05 (0.38) 0.12 [ -0.04, 0.28 ]
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Analysis 5.1. Comparison 5 AOM - malaise; delayed versus immediate antibiotics, Outcome 1 Malaise on
day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; delayed versus immediate antibiotics
Outcome: 1 Malaise on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 2001 45/150 19/135 2.62 [ 1.44, 4.76 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 5.2. Comparison 5 AOM - malaise; delayed versus immediate antibiotics, Outcome 2 Malaise
severity on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; delayed versus immediate antibiotics
Outcome: 2 Malaise severity on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 150 0.83 (1.69) 134 0.4 (0.97) 0.43 [ 0.11, 0.75 ]
-10 -5 0 5 10
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Analysis 5.3. Comparison 5 AOM - malaise; delayed versus immediate antibiotics, Outcome 3 Malaise
severity on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 5 AOM - malaise; delayed versus immediate antibiotics
Outcome: 3 Malaise severity on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 150 2.23 (2) 135 1.54 (1.22) 0.69 [ 0.31, 1.07 ]
-10 -5 0 5 10
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Analysis 6.1. Comparison 6 Supplementary medicine consumption; delayed versus immediate antibiotics,
Outcome 1 Spoons of paracetamol/day.
Review: Delayed antibiotics for respiratory infections
Comparison: 6 Supplementary medicine consumption; delayed versus immediate antibiotics
Outcome: 1 Spoons of paracetamol/day
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2001 149 2.28 (1.67) 133 1.69 (1.22) 0.59 [ 0.25, 0.93 ]
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Analysis 6.2. Comparison 6 Supplementary medicine consumption; delayed versus immediate antibiotics,
Outcome 2 Use of paracetamol and ibuprofen.
Review: Delayed antibiotics for respiratory infections
Comparison: 6 Supplementary medicine consumption; delayed versus immediate antibiotics
Outcome: 2 Use of paracetamol and ibuprofen
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 123/132 120/133 1.48 [ 0.61, 3.59 ]
0.1 0.2 0.5 1 2 5 10
Favours delayed antibiotics Favours immediate antibiotics
Analysis 7.1. Comparison 7 AOM - fever; delayed versus immediate antibiotics, Outcome 1 Fever Days 4 to
6.
Review: Delayed antibiotics for respiratory infections
Comparison: 7 AOM - fever; delayed versus immediate antibiotics
Outcome: 1 Fever Days 4 to 6
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Spiro 2006 42/132 46/133 0.88 [ 0.53, 1.47 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 8.1. Comparison 8 AOM - pain; delayed versus no antibiotics, Outcome 1 Otitis media pain on Day
3 delayed versus none.
Review: Delayed antibiotics for respiratory infections
Comparison: 8 AOM - pain; delayed versus no antibiotics
Outcome: 1 Otitis media pain on Day 3 delayed versus none
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 26/106 29/100 0.80 [ 0.43, 1.48 ]
0.01 0.1 1 10 100
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Analysis 9.1. Comparison 9 AOM - fever; delayed versus no antibiotics, Outcome 1 Otitis media number of
patients with fever on day 3 delayed versus none.
Review: Delayed antibiotics for respiratory infections
Comparison: 9 AOM - fever; delayed versus no antibiotics
Outcome: 1 Otitis media number of patients with fever on day 3 delayed versus none
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chao 2008 18/106 8/100 2.35 [ 0.97, 5.69 ]
0.01 0.1 1 10 100
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Analysis 10.1. Comparison 10 Common cold - pain; delayed versus immediate antibiotics, Outcome 1 Pain
on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 10 Common cold - pain; delayed versus immediate antibiotics
Outcome: 1 Pain on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 13/61 9/58 1.47 [ 0.58, 3.77 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 10.2. Comparison 10 Common cold - pain; delayed versus immediate antibiotics, Outcome 2 Pain
on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 10 Common cold - pain; delayed versus immediate antibiotics
Outcome: 2 Pain on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 1/61 3/58 0.31 [ 0.03, 3.03 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 11.1. Comparison 11 Common cold - fever; delayed versus immediate antibiotics, Outcome 1
Fever on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; delayed versus immediate antibiotics
Outcome: 1 Fever on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 5/67 6/62 0.75 [ 0.22, 2.60 ]
0.1 0.2 0.5 1 2 5 10
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Analysis 11.2. Comparison 11 Common cold - fever; delayed versus immediate antibiotics, Outcome 2
Fever on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; delayed versus immediate antibiotics
Outcome: 2 Fever on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 3/67 4/62 0.68 [ 0.15, 3.17 ]
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Analysis 11.3. Comparison 11 Common cold - fever; delayed versus immediate antibiotics, Outcome 3
Fever severity on day 1.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; delayed versus immediate antibiotics
Outcome: 3 Fever severity on day 1
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 67 36.74 (0.65) 61 36.87 (0.68) -0.13 [ -0.36, 0.10 ]
-10 -5 0 5 10
Favours Delayed antibiotics Favours Immediate antibiotics
Analysis 11.4. Comparison 11 Common cold - fever; delayed versus immediate antibiotics, Outcome 4
Fever severity on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; delayed versus immediate antibiotics
Outcome: 4 Fever severity on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 61 36.15 (0.73) 58 36.39 (0.58) -0.24 [ -0.48, 0.00 ]
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Analysis 11.5. Comparison 11 Common cold - fever; delayed versus immediate antibiotics, Outcome 5
Fever severity on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 11 Common cold - fever; delayed versus immediate antibiotics
Outcome: 5 Fever severity on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Arroll 2002a 59 36 (0.77) 60 36.32 (0.58) -0.32 [ -0.57, -0.07 ]
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Analysis 12.1. Comparison 12 Common cold - cough; delayed versus immediate antibiotics, Outcome 1
Cough on day 3.
Review: Delayed antibiotics for respiratory infections
Comparison: 12 Common cold - cough; delayed versus immediate antibiotics
Outcome: 1 Cough on day 3
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 54/67 51/62 0.90 [ 0.37, 2.18 ]
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Analysis 12.2. Comparison 12 Common cold - cough; delayed versus immediate antibiotics, Outcome 2
Cough on day 7.
Review: Delayed antibiotics for respiratory infections
Comparison: 12 Common cold - cough; delayed versus immediate antibiotics
Outcome: 2 Cough on day 7
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 41/61 43/58 0.72 [ 0.32, 1.58 ]
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Analysis 13.1. Comparison 13 Antibiotic use: delayed versus immediate antibiotics, Outcome 1 Antibiotic
use: delayed versus immediate antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 13 Antibiotic use: delayed versus immediate antibiotics
Outcome: 1 Antibiotic use: delayed versus immediate antibiotics
Study or subgroup Delayed Immediate Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Antibiotic use: delayed (prescription at time of visit) versus immediate antibiotics
Arroll 2002a 32/67 55/67 0.20 [ 0.09, 0.44 ]
Spiro 2006 50/132 116/133 0.09 [ 0.05, 0.17 ]
2 Antibiotic use: delayed (return for prescription) versus immediate antibiotics
Dowell 2001 43/95 92/92 0.00 [ 0.00, 0.07 ]
Little 1997 55/176 210/211 0.00 [ 0.00, 0.02 ]
Little 2001 36/150 132/151 0.05 [ 0.02, 0.08 ]
Little 2005a 39/197 185/193 0.01 [ 0.00, 0.02 ]
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Analysis 14.1. Comparison 14 Antibiotic use: delayed versus no antibiotics, Outcome 1 Antibiotic use:
delayed versus no antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 14 Antibiotic use: delayed versus no antibiotics
Outcome: 1 Antibiotic use: delayed versus no antibiotics
Study or subgroup Delayed No Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Antibiotic use: delayed (prescription at time of visit) versus no antibiotics
Chao 2008 40/106 13/100 4.06 [ 2.01, 8.19 ]
2 Antibiotic use: delayed (return for prescription) versus no antibiotics
Little 1997 55/176 23/184 3.18 [ 1.85, 5.46 ]
Little 2005a 39/197 29/182 1.30 [ 0.77, 2.21 ]
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Analysis 15.1. Comparison 15 Patient satisfaction: delayed versus immediate antibiotics, Outcome 1
Patient satisfaction: delayed versus immediate antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 15 Patient satisfaction: delayed versus immediate antibiotics
Outcome: 1 Patient satisfaction: delayed versus immediate antibiotics
Study or subgroup Delayed antibiotic Immediate antibiotic Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Patient satisfaction: delayed (prescription at time of consult) versus immediate antibiotics
Arroll 2002a 64/67 58/62 6.3 % 1.47 [ 0.32, 6.85 ]
Subtotal (95% CI) 67 62 6.3 % 1.47 [ 0.32, 6.85 ]
Total events: 64 (Delayed antibiotic), 58 (Immediate antibiotic)
Heterogeneity: not applicable
Test for overall effect: Z = 0.49 (P = 0.62)
2 Patient satisfaction: delayed (return for prescription) versus immediate antibiotics
Dowell 2001 71/73 75/75 1.6 % 0.19 [ 0.01, 4.01 ]
Little 1997 165/177 202/211 18.1 % 0.61 [ 0.25, 1.49 ]
Little 2001 115/150 123/135 27.8 % 0.32 [ 0.16, 0.65 ]
Little 2005a 147/190 166/194 46.1 % 0.58 [ 0.34, 0.97 ]
Subtotal (95% CI) 590 615 93.7 % 0.48 [ 0.33, 0.71 ]
Total events: 498 (Delayed antibiotic), 566 (Immediate antibiotic)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.39, df = 3 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 3.77 (P = 0.00016)
Total (95% CI) 657 677 100.0 % 0.52 [ 0.35, 0.76 ]
Total events: 562 (Delayed antibiotic), 624 (Immediate antibiotic)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.28, df = 4 (P = 0.37); I2 =6%
Test for overall effect: Z = 3.31 (P = 0.00092)
Test for subgroup differences: Chi2 = 1.89, df = 1 (P = 0.17), I2 =47%
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Analysis 16.1. Comparison 16 Patient satisfaction: delayed versus no antibiotics, Outcome 1 Patient
satisfaction: delayed versus no antibiotics.
Review: Delayed antibiotics for respiratory infections
Comparison: 16 Patient satisfaction: delayed versus no antibiotics
Outcome: 1 Patient satisfaction: delayed versus no antibiotics
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Patient satisfaction: delayed (prescription provided at visit) versus no antibiotics
Chao 2008 101/106 91/100 11.1 % 2.00 [ 0.65, 6.18 ]
Subtotal (95% CI) 106 100 11.1 % 2.00 [ 0.65, 6.18 ]
Total events: 101 (Delayed antibiotics), 91 (No antibiotics)
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
2 Patient satisfaction: delayed (return for prescription) versus no antibiotics
Little 1997 165/177 166/184 24.5 % 1.49 [ 0.70, 3.19 ]
Little 2005a 147/190 130/181 64.4 % 1.34 [ 0.84, 2.14 ]
Subtotal (95% CI) 367 365 88.9 % 1.38 [ 0.93, 2.06 ]
Total events: 312 (Delayed antibiotics), 296 (No antibiotics)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 1.58 (P = 0.11)
Total (95% CI) 473 465 100.0 % 1.44 [ 0.99, 2.10 ]
Total events: 413 (Delayed antibiotics), 387 (No antibiotics)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.42, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.058)
Test for subgroup differences: Chi2 = 0.37, df = 1 (P = 0.55), I2 =0.0%
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Analysis 17.1. Comparison 17 Adverse events: delayed versus immediate antibiotics, Outcome 1 Vomiting.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: delayed versus immediate antibiotics
Outcome: 1 Vomiting
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
El-Daher 1991 57/118 4/111 25.00 [ 8.65, 72.25 ]
Little 1997 15/179 18/215 1.00 [ 0.49, 2.05 ]
Spiro 2006 15/132 15/133 1.01 [ 0.47, 2.16 ]
0.001 0.01 0.1 1 10 100 1000
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Analysis 17.2. Comparison 17 Adverse events: delayed versus immediate antibiotics, Outcome 2 Diarrhoea.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: delayed versus immediate antibiotics
Outcome: 2 Diarrhoea
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Arroll 2002a 11/67 12/62 0.82 [ 0.33, 2.02 ]
Little 1997 23/179 23/215 1.23 [ 0.67, 2.28 ]
Little 2001 14/150 25/135 0.45 [ 0.22, 0.91 ]
Spiro 2006 10/132 31/133 0.27 [ 0.13, 0.58 ]
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Analysis 17.3. Comparison 17 Adverse events: delayed versus immediate antibiotics, Outcome 3 Rash.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: delayed versus immediate antibiotics
Outcome: 3 Rash
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 11/180 14/215 0.93 [ 0.41, 2.11 ]
Little 2001 8/150 6/135 1.21 [ 0.41, 3.58 ]
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Analysis 17.4. Comparison 17 Adverse events: delayed versus immediate antibiotics, Outcome 4 Stomach
ache.
Review: Delayed antibiotics for respiratory infections
Comparison: 17 Adverse events: delayed versus immediate antibiotics
Outcome: 4 Stomach ache
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 48/180 66/215 0.82 [ 0.53, 1.27 ]
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Analysis 18.1. Comparison 18 Adverse events: delayed versus no antibiotics, Outcome 1 Vomiting.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: delayed versus no antibiotics
Outcome: 1 Vomiting
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 15/179 22/186 0.68 [ 0.34, 1.36 ]
0.01 0.1 1 10 100
Favours Delayed antibiotics Favours No antibiotics
Analysis 18.2. Comparison 18 Adverse events: delayed versus no antibiotics, Outcome 2 Diarrhoea.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: delayed versus no antibiotics
Outcome: 2 Diarrhoea
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chao 2008 0/106 0/100 Not estimable
Little 1997 23/179 16/186 1.57 [ 0.80, 3.07 ]
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Favours Delayed antibiotics Favours No antibiotics
49Delayed antibiotics for respiratory infections (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 18.3. Comparison 18 Adverse events: delayed versus no antibiotics, Outcome 3 Rash.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: delayed versus no antibiotics
Outcome: 3 Rash
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 11/179 21/186 0.51 [ 0.24, 1.10 ]
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Analysis 18.4. Comparison 18 Adverse events: delayed versus no antibiotics, Outcome 4 Stomach ache.
Review: Delayed antibiotics for respiratory infections
Comparison: 18 Adverse events: delayed versus no antibiotics
Outcome: 4 Stomach ache
Study or subgroup Delayed antibiotics No antibiotics Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Little 1997 48/179 52/186 0.94 [ 0.60, 1.50 ]
0.01 0.1 1 10 100
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Analysis 19.1. Comparison 19 Re-consultation rate; delayed versus immediate antibiotics, Outcome 1 Re-
consultation rate.
Review: Delayed antibiotics for respiratory infections
Comparison: 19 Re-consultation rate; delayed versus immediate antibiotics
Outcome: 1 Re-consultation rate
Study or subgroup Delayed antibiotics
Immediate
antibiotics Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Pichichero 1987 8/55 10/59 45.5 % 0.83 [ 0.30, 2.29 ]
Spiro 2006 13/132 11/133 54.5 % 1.21 [ 0.52, 2.81 ]
Total (95% CI) 187 192 100.0 % 1.04 [ 0.55, 1.98 ]
Total events: 21 (Delayed antibiotics), 21 (Immediate antibiotics)
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.91)
Test for subgroup differences: Not applicable
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Analysis 20.1. Comparison 20 Subsequent consultation rates in the 12 months following the index
consultation (excluding first month following consultation); delayed versus immediate antibiotics, Outcome 1
Re-consultation in the 12 months following the index consultation (excluding the first month following the
index consultation).
Review: Delayed antibiotics for respiratory infections
Comparison: 20 Subsequent consultation rates in the 12 months following the index consultation (excluding first month following consultation); delayed versus immediate
antibiotics
Outcome: 1 Re-consultation in the 12 months following the index consultation (excluding the first month following the index consultation)
Study or subgroup log [Rate Ratio] Rate Ratio Rate Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Little 2005a -0.21 (0.24) 0.81 [ 0.51, 1.30 ]
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A D D I T I O N A L T A B L E S
Table 1. Summary of outcomes
Study Outcome Favours Result (with 95% CI) Notes
Sore throat
Outcomes in this ta-
ble are the result of a
comparison between de-
layed and immediate an-
tibiotics unless otherwise
specified
Pichichero 1987 Fever severity on day 3 SMD0.40 (0.05 to 0.75)
Malaise severity on day 3 No difference MD0.20 (-0.11 to 0.51)
Pain severity on day 3 No difference MD0.30 (-0.15 to 0.75)
Compliance No difference 100% in both groups
Gerber 1990 Recurrence rate No difference
Compliance Delayed antibiotics 88% in immediate group
and 93% in the delayed
group
El Daher 1991 Vomiting Immediate antibiotics OR 25.00 (8.65 to 72.
25)
Pain on day 3 Immediate antibiotics OR 14.51 (7.14 to 29.
50)
Malaise on day 3 Immediate antibiotics OR 16.49 (5.68 to 47.
83)
Fever severity on day 3 Immediate antibiotics SMD0.58 (0.31 to 0.84)
Compliance
Little 1997 Vomiting No difference OR 1.00 (0.49 to 2.05)
Diarrhoea No difference OR 1.23 (0.67 to 2.28)
Rash No difference OR 0.93 (0.41 to 2.11)
Stomach ache No difference OR 0.82 (0.53 to 1.27)
Fever (> 37.0 ºC) Immediate antibiotics
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Table 1. Summary of outcomes (Continued)
Sore throat No difference
Cough No difference
Malaise No difference
Analgesic use No difference
Time off work No difference
AOM
Little 2001 Diarrhoea Delayed antibiotics OR 0.45 (0.22 to 0.91)
Rash No difference OR 1.21 (0.41 to 2.58)
Patientswith pain onday
3
No difference OR 1.93 (0.96 to 3.88)
Patientswith pain onday
7
No difference OR 6.55 (0.33 to 128.
35)
Patients with malaise on
day 3
Immediate antibiotics OR 2.62 (1.44 to 4.76)
Malaise severity day 3 Immediate antibiotics MD 0.43 (0.11 to 0.75)
Malaise severity on day 7 No difference MD0.01 (-0.11 to 0.13)
Pain severity on day 3 Immediate antibiotics MD 0.75 (0.26 to 1.24)
Pain severity on day 7 No difference MD0.12 (-0.04 to 0.28)
Paracetamol consump-
tion
Immediate antibiotics MD 0.59 (0.25 to 0.93)
Last day of crying Immediate antibiotics MD 0.69 (0.31 to 1.07)
Little 2001 (published in
Little 2006)
Episodes of earache in
the 3 months since ran-
domisation
No difference OR 0.89 (0.48 to 1.65)
Episodes of earache over
1 year
No difference OR 1.03 (0.6 to 1.78)
Spiro 2006 Fever day 4 to 6 No difference OR 0.88 (0.53 to 1.47)
Vomiting No difference OR 1.01 (0.47 to 2.16)
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Table 1. Summary of outcomes (Continued)
Diarrhoea Delayed antibiotics OR 0.27 (0.13 to 0.58)
Chao 2008 Fever day 3 No difference OR 1.45 (0.50 to 4.24)
Pain day 3 No difference OR 0.64 (0.29 to 1.38)
Cough
Dowell 2001 Clinical outcomes No difference
Little 2005a All clinical outcomes No difference
Common cold
Arroll 2002 Patients with fever on
day 3
No difference OR 0.75 (0.22 to 2.6)
Patients with fever on
day 7
No difference OR 0.68 (0.15 to 3.17)
Patients with diarrhoea No difference OR 0.79 (0.53 to 1.19)
Patientswith pain onday
3
No difference OR 1.47 (0.58 to 3.77)
Patientswith pain onday
7
No difference OR 0.31 (0.03 to 3.03)
Patients with cough on
day 3
No difference OR 0.90 (0.37 to 2.18)
Patients with cough on
day 7
No difference OR 0.72 (0.32 to 1.58)
Fever severity day 3 No difference MD -0.24 (-0.48 to 0.
00)
Fever severity on day 7 Delayed antibiotics MD -0.32 (-0.57 to -0.
07)
Mean temperature for
both < 37 ºC
Antibiotic use
Sore throat
Little 1997 Antibiotic use (none ver-
sus delayed)
No antibiotics (least an-
tibiotic use)
OR 3.18 (1.85 to 5.46)
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Table 1. Summary of outcomes (Continued)
Antibiotic use (delayed
versus immediate)
Delayed antibiotics (less
than immediate)
OR 0.00 (0.00 to 0.02)
AOM
Little 2001 Antibiotic use Delayed antibiotics OR 0.05 (0.02 to 0.08)
Spiro 2006 Antibiotic use Delayed antibiotics OR 0.09 (0.05 to 0.17)
Chao 2008 Antibiotic use No antibiotics OR 4.06 (2.01 to 8.19)
Cough
Dowell 2001 Antibiotic use Delayed antibiotics OR 0.00 (0.00 to 0.07)
Little 2005 Antibiotic use (none ver-
sus delayed)
No difference OR 1.30 (0.77 to 2.21)
Little 2005 Antibiotic use (delayed
versus immediate)
Delayed antibiotics OR 0.01 (0.00 to 0.02)
Common cold
Arroll 2002 Antibiotic use Delayed antibiotics OR 0.20 (0.09 to 0.44)
Patient satisfaction
Sore throat
Little 1997 Patient satisfaction
(none versus delayed)
No difference OR 1.49 (0.70 to 3.19)
Patient satisfaction (de-
layed versus immediate)
No difference OR 0.61 (0.25 to 1.49)
AOM
Little 2001 Patient satisfaction (im-
mediate versus delayed)
Immediate antibiotics OR 0.32 (0.16 to 0.65)
Chao 2008 Patient satisfaction (de-
layed versus none)
No difference OR 2.00 (0.65 to 6.18)
Cough
Dowell 2001 Patient satisfaction Immediate antibiotics OR 0.19 (0.01 to 4.01)
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Table 1. Summary of outcomes (Continued)
Little 2005 Patient satisfaction
(none versus delayed)
No difference OR 1.34 (0.84 to 2.14)
Little 2005 Patient satisfaction (de-
layed versus immediate)
Immediate antibiotics OR 0.58 (0.34 to 0.97)
Common cold
Arroll 2002 Patient satisfaction No difference OR 1.47 (0.32 to 6.85)
Secondary outcomes
Sore throat
Pichichero 1987 Re-consultation rate No difference OR 0.83 (0.30 to 2.29)
AOM
Spiro 2006 Re-consultation rate No difference OR 1.21 (0.52 to 2.81)
LRTI
Little 2005a (published
in Moore 2009)
Re-consultation in the
year following the index
consultation (excluding
the firstmonth after con-
sultation)
No difference IRR 0.81 (0.51 to 1.28)
AOM: acute otitis media
CI: confidence interval
IRR: incident rate ratio
LRTI: lower respiratory tract infection
MD: mean difference
OR: odds ratio
SMD: standardised mean difference
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A P P E N D I C E S
Appendix 1. Ovid EMBASE search strategy
1 exp Respiratory Tract Infection/ (172448)
2 exp Upper Respiratory Tract Infection/ (22007)
3 (upper respiratory tract infection$ or urti).mp. (14226)
4 exp Otitis Media/ (15047)
5 otitis media.mp. (16846)
6 exp Pharyngitis/ (13679)
7 pharyngitis.mp. (9017)
8 exp Tonsillitis/ (5085)
9 tonsillitis.mp. (4596)
10 exp Common Cold/ (4421)
11 common cold.mp. (5401)
12 exp Bronchitis/ (24102)
13 bronchitis.mp. (17391)
14 exp Sinusitis/ (19381)
15 sinusitis.mp. (18397)
16 sore throat$.mp. (8421)
17 or/1-16 (234854)
18 exp Antibiotic Agent/ (544500)
19 antibiotic$.mp. (328859)
20 or/18-19 (628363)
21 (delay$ adj15 prescri$).mp. (841)
22 17 and 20 and 21 (102)
Appendix 2. CENTRAL search strategy
#1 MeSH descriptor: [Respiratory Tract Infections] explode all trees 9072
#2 (upper next respiratory next tract infection*) or URTI 1061
#3 MeSH descriptor: [Otitis Media] explode all trees 1009
#4 otitis next media 1926
#5 MeSH descriptor: [Pharyngitis] explode all trees 841
#6 pharyngitis 1237
#7 MeSH descriptor: [Tonsillitis] explode all trees 322
#8 tonsillitis 651
#9 MeSH descriptor: [Common Cold] explode all trees 375
#10 common next cold* 729
#11 MeSH descriptor: [Bronchitis] explode all trees 1416
#12 bronchitis 2754
#13 MeSH descriptor: [Sinusitis] explode all trees 626
#14 sinusitis 1362
#15 sore next throat* 826
#16 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 14213
#17 MeSH descriptor: [Anti-Bacterial Agents] explode all trees 8199
#18 antibiotic* 15634
#19 #17 or #18 19843
#20 delay* near/15 prescri* 87
#21 #16 and #19 and #20 28
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Appendix 3. EBSCO CINAHL search strategy
S15 S10 and S13 and S14
S14 TI delay* N15 prescri* or AB delay* N15 prescri*
S13 S11 or S12
S12 TI antibiotic* or AB antibiotic*
S11 (MH “Antibiotics+”)
S10 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9
S9 TI ( otitis media or pharyngitis or tonsillitis or common cold* or bronchitis or sinusitis or sore throat* ) or AB ( otitis media or
pharyngitis or tonsillitis or common cold* or bronchitis or sinusitis or sore throat* )
S8 (MH “Sinusitis+”)
S7 (MH “Bronchitis+”)
S6 (MH “Common Cold”)
S5 (MH “Tonsillitis+”)
S4 (MH “Pharyngitis”)
S3 (MH “Otitis Media+”)
S2 TI ( upper respiratory tract infection* or urti ) or AB ( upper respiratory tract infection* or urti )
S1 (MH “Respiratory Tract Infections+”)
Appendix 4. ISI Current Contents Connect search strategy
#14 #13 AND #12 AND #9
#13 TS=antibiotic*
#12 #11 OR #10
#11 TS=immediate*
#10 TS=delay*
#9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
#8 TS=sore throat
#7 TS=sinusitis
#6 TS=bronchitis
#5 TS=common cold*
#4 TS=tonsillitis
#3 TS=pharyngitis
#2 TS=otitis media
#1 TS=respiratory tract infection*
F E E D B A C K
Feedback: Analysis 15.01 Comparison 15 may have some errors, 9 June 2008
Summary
Feedback: Analysis 15.01 Comparison 15 Patient satisfaction immediate versus delayed antibiotics, Outcome 01 Patient satisfaction:
immediate versus delayed antibiotics may have some errors.
We think that the extracted data has been entered under the wrong headings, i.e. for Little 1997, it reports that 165/177 were satisfied
with delayed antibiotics but the RevMan forest plot has 165/177 under the immediate antibiotics.
Data extracted from one article (Dowell 2001) may have been entered incorrectly, i.e. the percentage has been entered into RevMan
directly rather than as the actual number. In other words, for Dowell 2001, the paper reports 100% (73% very satisfied and 27%
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moderately satisfied), whereas the forest plot has reported the 73% as 73/75. This is a double query ? see below for issue of inconsistent
grouping of satisfaction scores.
Suggest that the data extracted for Dowell 2001 should be consistent with the logic used for Arroll 2002 in their results for the same
outcome.
We think that possibly the forest plot analysis should be conducted with the figures below. We have looked at all the original papers.
Arroll 2002a
64/67* Delayed Antibiotics
58/62* Immediate Antibiotics
Dowell 2001
71/73# Delayed Antibiotics
75/75# Immediate Antibiotics
Little 1997
165/177 Delayed Antibiotics
202/211 Immediate Antibiotics
Little 2001
115/150 Delayed Antibiotics
123/135 Immediate Antibiotics
Little 2005a
147/190 Delayed Antibiotics
166/194 Immediate Antibiotics
Arroll et al noted that for these results, groups responding 1 and 2 have been combined and groups 3 and 4 have been combined
where: 1= very satisfied; 2= moderately satisfied; 3 = slightly satisfied; 4 = not at all satisfied.
Using similar logic as Arroll et al, results for groups responding ?very satisfied? and ?moderately satisfied? have been combined, as have
?not very satisfied? and ?not at all satisfied? to get the figures in the table above for Dowell 2001. (Note: in the review table, the figures
were extracted directly from the ?very satisfied? column only, where they were presented as a percentage without then recalculating
them as a whole figure).
We don’t think these possible errors effect the overall conclusions made by the authors in the review.
Submitter agrees with default conflict of interest statement:
I certify that I have no affiliations with or involvement in any organisation or entity with a financial interest in the subject matter of
my feedback.
Reply
We thank those who have given feedback on this review. We greatly appreciate the work you have done to uncover these errors and
the opportunity you have given us to correct them. We agree with all the feedback you have submitted and have made corrections
to analysis 15 comparison 15.1, analysis 16 comparison 16.1, analysis 13 comparison 13.1 (antibiotic use delayed versus immediate),
analysis 14 comparison 14.1 (antibiotic use delayed versus none) and analysis 3 comparison 3.1 (fever severity on day 3). We have also
added an analysis 17: adverse events delayed versus no antibiotics.
Theses changes have not fundamentally changed the results of the review. However the text and outcome tables have been amended to
reflect changes made.
Geoff Spurling, Chris Del Mar, Liz Dooley
Feedback reply added 25 June 2008
Contributors
Dianne Lowe, Rebecca Ryan
Feedback comment added 16 June 2008
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It would be interesting to explore the comparative evidence base for the most effective method of
delayed prescription, 18 March 2009
Summary
Feedback: It would be interesting to explore the comparative evidence base for the most effective method of “delayed prescription” e.g.:
1. Script dated today given to patient
2. Script dated 2-3 days from now - given to patient
3. Script held at practice
Submitter agrees with default conflict of interest statement:
I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of
my feedback.
Reply
We thank you for your feedback on this review. We agree that it would be interesting to explore the comparative evidence base for
the most effective method of delayed prescription. Subgroups highlighting the method of delayed prescribing have been added for the
outcomes antibiotic use and patient satisfaction. Unfortunately, there was great heterogeneity in the methods of delayed prescribing
that makes combining studies difficult. Methods of delayed prescribing ranged from issuing a prescription at the time of the initial
consults with instruction to delay, to holding the delayed prescription at reception to be picked up if symptoms hadn’t improved after
a specified period of time. The recommended periods of delay ranged from three to fourteen days.
The three studies included in this systematic review published prior to 1992 examined the concern that immediate antibiotics for
streptococcal pharyngitis might impair the body’s immune response and predispose the patient to a relapse of pharyngitis. Six of the
included studies published after 1992 were conducted to evaluate the role of delayed antibiotics as a way of reducing antibiotic use for
respiratory infections compared to immediate antibiotics. While all six studies found that antibiotic use was significantly reduced in
the delayed antibiotic group compared to the immediate antibiotic group. There were significant differences in the way antibiotics were
delayed which may have contributed to the marked heterogeneity of this result. Of the seven studies published after 1991, four had the
delayed script kept at reception to be picked up (Dowell 2001; Little 1997; Little 2001; Little 2005a) and in three, the script was issued
to patients with instructions to delay (Arroll 2002a; Chao 2008; Spiro 2006). For the delayed arms of the four studies where the script
was left at reception, antibiotics were used in 28% of cases (173/618) compared with antibiotics being used in 40% of cases (122/305)
where antibiotics were issued to patients with instructions to delay.
None of the included studies specifically addressed whether or not prescriptions had been post-dated. However, a recent randomised
controlled trial published in 2010, (Worrall 2010) comparing delayed prescriptions dated either the day of the office visit or 2 days later,
but not comparing with either immediate or no antibiotics, demonstrated no significant difference between the two groups in terms of
antibiotic use.
Geoff Spurling, Chris Del Mar, Liz Dooley, Rebecca Farley
Feedback reply added 25 March 2012
Contributors
Jas Janjuha, Occupation Pharmacist
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WH A T ’ S N E W
Last assessed as up-to-date: 28 February 2013.
Date Event Description
28 February 2013 New search has been performed The searches have beenupdated.Twonewpapers (Little
2006; Moore 2009) were included. They reported
longer-term outcomes of two previously included stud-
ies (Little 2001; Little 2005a) including impact of de-
layed antibiotic prescribing on earache recurrence and
subsequent consultation rates in the 12 months fol-
lowing the initial consultation. Three new trials were
excluded (Fischer 2009; Newson 2009; Vouloumanou
2009). Our conclusions remain unchanged.
28 February 2013 New citation required but conclusions have not
changed
A new author joined the team to update the review.
H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 4, 2004
Date Event Description
5 August 2010 Amended Contact details updated.
27 March 2009 New search has been performed Searches conducted. This 2009 update contains one new study (Chao 2008)
and Feedback on a comment submitted via The Cochrane Library.
16 June 2008 Feedback has been incorporated Feedback comment added.
16 June 2008 Amended Converted to new review format.
21 January 2007 New search has been performed Searches conducted.
9 January 2004 New search has been performed Searches conducted.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Acute Disease; Anti-Bacterial Agents [∗administration & dosage]; Common Cold [drug therapy]; Cough [drug therapy]; Drug Admin-
istration Schedule; Fever [∗drug therapy; etiology]; Otitis Media [drug therapy]; Pain [drug therapy]; Patient Satisfaction; Pharyngitis
[drug therapy]; Randomized Controlled Trials as Topic; Respiratory Tract Infections [complications; ∗drug therapy]
MeSH check words
Humans
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